What is the management of placenta after a 12-week delivery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Placenta After 12-Week Delivery

For a 12-week delivery, expectant management of the placenta is recommended, with manual removal only indicated in cases of severe, uncontrollable hemorrhage. 1

Initial Management Approach

Expectant Management

  • Allow for spontaneous placental delivery without manual intervention
  • Monitor for signs of placental separation (small gush of blood, cord lengthening)
  • The World Health Organization defines retained placenta as spontaneous placental delivery not occurring within 30 minutes after fetal expulsion 1

Pharmacological Management

  • Administer oxytocin 5-10 IU slow IV or intramuscular injection immediately after delivery to reduce the risk of postpartum hemorrhage 1
  • Avoid methylergonovine (Methergine) as it carries risk (>10%) of vasoconstriction and hypertension 1, despite its FDA approval for routine management after placental delivery 2, 3

When to Consider Manual Removal

Manual removal of the placenta should not be routinely performed at 12 weeks gestation except in the following circumstances:

  • Severe and uncontrollable hemorrhage 1
  • No signs of placental separation after 30-60 minutes with active bleeding

Alternative Approaches Before Manual Removal

If the placenta remains retained after 20-30 minutes:

  1. Intraumbilical Oxytocin:

    • Consider intraumbilical vein injection of oxytocin (20 IU in 20 mL saline) 4, 5
    • This approach has shown significant reduction in the need for manual removal (30% vs 67.7%) 5
    • Studies demonstrate increased spontaneous expulsion of placenta within 45-60 minutes after injection 4, 6
  2. Controlled Cord Traction:

    • Apply gentle traction on the umbilical cord while providing counter-pressure on the uterus
    • Avoid excessive force which could cause cord avulsion or uterine inversion

Monitoring During Third Stage

  • Monitor vital signs closely
  • Observe for excessive bleeding (>500 mL is considered postpartum hemorrhage)
  • Position patient in lateral decubitus position to attenuate hemodynamic impact 1

Management of Complications

If Hemorrhage Occurs:

  • Administer tranexamic acid 1g IV within 1-3 hours of bleeding onset to reduce maternal morbidity and mortality 1
  • Ensure IV access and availability of blood products if needed
  • Prostaglandin F analogues can be used to treat postpartum hemorrhage unless increase in pulmonary artery pressure is undesirable 1

Special Considerations

For patients at 12 weeks gestation, the risk of placenta accreta spectrum is extremely low unless there is a history of prior cesarean deliveries or uterine surgeries 7. However, if placenta accreta is suspected:

  • Pause the procedure
  • Alert anesthesia team
  • Obtain additional IV access
  • Order blood products
  • Consider transfer to a higher level of care if available 7

Pitfalls and Caveats

  1. Avoid routine manual removal - This increases the risk of infection, trauma, and hemorrhage
  2. Don't delay intervention for severe bleeding - While expectant management is preferred, prompt action is needed for heavy bleeding
  3. Be cautious with oxytocin dosing - Higher doses (80 units) may decrease the need for additional treatment but standard doses (10 units) are typically sufficient 8
  4. Remember the physiological mechanism - The primary mechanism to stem bleeding from the placental bed is sustained myometrial contraction, not the hemostatic system 1

By following this approach, you can minimize maternal morbidity while appropriately managing the placenta after a 12-week delivery.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.